Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study materials have been shared with international collaborators in more than 15 countries. This new funding will support the development of further collaborations, enable work to bring together datasets and make the linked data open access, as well as help increase recruitment to the study, especially among harder to reach groups.

Dr Polly Waite, co-lead of the study, said, 

 

We are delighted to have been awarded funding from UKRI to support the Co-SPACE study and it's sister survey for parents/carers of pre-school children, Co-SPYCE. So far over 7,500 families have taken part. The findings will help us identify what protects children and young people from deteriorating mental health over time, what support families need and how this may vary according to different contexts. - Dr Polly Waite.

 

The project is tracking children and young people’s mental health throughout the COVID-19 crisis through a monthly online survey by parents/carers of children aged 2-16 years and young people themselves (if aged 11-16 years).

Analysis of the data will be supported by the Oxford Brain Health Clinical Trials Unit. To develop a richer understanding of people's experiences, qualitative interviews will be conducted with parents/carers, young people and people who work with them. All of this will be done with rapid and meaningful engagement with families, children and young people, health professionals, charities and interested parties throughout. 

For more information. 

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

New UK Pandemic Ethics Accelerator Brings Ethical Thinking into Pandemic Policy-Making

COVID-19

The UK Pandemic Ethics Accelerator, which launched today, harnesses and mobilises the UK’s internationally renowned expertise in ethics research. Four major UK universities and the Nuffield Council on Bioethics form the collaborative.

Risk of Rare Blood Clotting Higher for COVID-19 than for Vaccines

COVID-19

Researchers at the University of Oxford have today reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza.

No Evidence of Significant Increase in Risk of Suicide in First Months of Pandemic

COVID-19 Mental Health Suicide

A new observational study is the first to examine suicides occurring during the early phase of the COVID-19 pandemic in multiple countries and finds that suicide numbers largely remained unchanged or declined in the pandemic’s early months, however continued monitoring is needed.

Largest study to date suggests link between COVID-19 infection and subsequent mental health and neurological conditions

COVID-19 Mental Health

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates.

Opportunities for Final Goodbyes Must be Prioritised in COVID-19 Pandemic

COVID-19 Child and Adolescent Psychiatry Mental Health

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.

Seven in Ten Patients Hospitalised with COVID-19 Not Fully Recovered After Five Months

COVID-19 Mental Health

The majority of survivors who left hospital following COVID-19 did not fully recover five months after discharge and continued to experience negative impacts on their physical and mental health, as well as ability to work, according to results released by the PHOSP-COVID study.